Membrane to cortex attachment determines different mechanical phenotypes in LGR5+ and LGR5- colorectal cancer cells

Colorectal cancer (CRC) tumors are composed of heterogeneous and plastic cell populations, including a pool of cancer stem cells that express LGR5. Whether these distinct cell populations display different mechanical properties, and how these properties might contribute to metastasis is poorly understood. Using CRC patient derived organoids (PDOs), we find that compared to LGR5- cells, LGR5+ cancer stem cells are stiffer, adhere better to the extracellular matrix (ECM), move slower both as single cells and clusters, display higher nuclear YAP, show a higher survival rate in response to mechanical confinement, and form larger transendothelial gaps. These differences are largely explained by the downregulation of the membrane to cortex attachment proteins Ezrin/Radixin/Moesin (ERMs) in the LGR5+ cells. By analyzing single cell RNA-sequencing (scRNA-seq) expression patterns from a patient cohort, we show that this downregulation is a robust signature of colorectal tumors. Our results show that LGR5- cells display a mechanically dynamic phenotype suitable for dissemination from the primary tumor whereas LGR5+ cells display a mechanically stable and resilient phenotype suitable for extravasation and metastatic growth.


Statistics
For all statistical analyses, confirm that the following items are present in in the figure legend, table legend, main text, or or Methods section.

n/a Confirmed
The exact sample size (n) for each experimental group/condition, given as as a discrete number and unit of of measurement A statement on on whether measurements were taken from distinct samples or or whether the same sample was measured repeatedly The statistical test(s) used AND whether they are one-or or two-sided Only common tests should be described solely by name; describe more complex techniques in the Methods section.

A description of of all covariates tested
A description of of any assumptions or or corrections, such as as tests of of normality and adjustment for multiple comparisons A full description of of the statistical parameters including central tendency (e.g.means) or or other basic estimates (e.g.regression coefficient) AND variation (e.g. standard deviation) or or associated estimates of of uncertainty (e.g.confidence intervals) For null hypothesis testing, the test statistic (e.g.F, t, r) with confidence intervals, effect sizes, degrees of of freedom and P value noted Give P values as exact values whenever suitable.
For Bayesian analysis, information on on the choice of of priors and Markov chain Monte Carlo settings For hierarchical and complex designs, identification of of the appropriate level for tests and full reporting of of outcomes Estimates of of effect sizes (e.g.Cohen's d, Pearson's r), ), indicating how they were calculated Our web collection on statistics for biologists contains articles on many of the points above.

Data analysis
For manuscripts utilizing custom algorithms or or software that are central to to the research but not yet described in in published literature, software must be be made available to to editors and reviewers.We We strongly encourage code deposition in in a community repository (e.g.GitHub).See the Nature Portfolio guidelines for submitting code & software for further information.

Data Policy information about availability of of data
All manuscripts must include a data availability statement This statement should provide the following information, where applicable: -Accession codes, unique identifiers, or or web links for publicly available datasets -A description of of any restrictions on on data availability -For clinical datasets or or third party data, please ensure that the statement adheres to to our policy MATLAB.version 9.6.0.1072779 (R2019a), MathWorks Inc., Natick, Massachusetts, 2019.Costum made codes can be be made available upon request to to the corresponding authors on on reasonable request.GraphPad Prism 9 was used for graph generation and for statistical analysis.Image/ Fiji was used for some image analysis and/or image processing.FlowJo (v10.7) and BD BD FACS DIVA were used for flow cytometry data analysis.
The RNA-seq data generated in in this study are available at at the Gene Expression Omnibus (GEO) with the accession number: GSE247359.Previously published single

Reporting on sex and gender
Reporting on race, ethnicity, or other socially relevant groupings

Recruitment
Ethics oversight Note that full information on the approval of the study protocol must also be provided in the manuscript.

Field-specific reporting
Please select the one below that is the best fit for your research.If you are not sure, read the appropriate sections before making your selection.

Life sciences Behavioural & social sciences Ecological, evolutionary & environmental sciences
For a reference copy of the document with all sections, see nature.com/documents/nr-reporting-summary-flat.pdf

Life sciences study design
All studies must disclose on these points even when the disclosure is negative.Describe how participants were recruited.Outline any potential self-selection bias or other biases that may be present and how these are likely to impact results.
Identify the organization(s) that approved the study protocol.
No statistical test was used to determine sample size upfront.Instead sample size was determined empirically according to previous knowledge of the variation similar experimental setups.For the majority of the experiments a minimum of n=2 independent experiments were performed, with multiple measurements per experiment, which is sufficient to detect meaningful differences based on historical record with similar experiments.
No data were excluded from this study.
The Bulk RNAseq experiment was performed once using two replicates for each sample.Replication of the data was at all times successful.Experiments were performed at different days and using different batches of PDOs, obtaining the same results.
In experiments involving comparison between groups, no particular method was used to randomize the experiments.Experimental groups for comparisons between LGR5+ and LG5med and LGR5-were allocated based on objective measurements of cell fluorescence, which prevents experimental biases.

nature portfolio | reporting summary
April 2023

Blinding
Reporting for specific materials, systems and methods We require information from authors about some types of materials, experimental systems and methods used in many studies.Here, indicate whether each material, system or method listed is relevant to your study.If you are not sure if a list item applies to your research, read the appropriate section before selecting a response.Blinding was not possible as the same researcher executed and analyzed the experiments.

Materials
The following is a list of the primary antibodies used and their respective dilutions were: mouse anti- 293 [HEK-293] is a cell line that was isolated from the kidney of a human embryo.
none of the cell lines were authenticated All the cell lines used tested negative for Mycoplasma.
Name any commonly misidentified cell lines used in the study and provide a rationale for their use.
data of CRC patient samples were reanalyzed and are available at GEO under accession codes GSE13246575.Count matrices for single-cell RNA-seq experiments were deposited at ArrayExpress under accession number E-MTAB-8107 and E-MTAB-9934.Data from healthy human samples can be found in the gut atlas human dataset (https://www.gutcellatlas.org), with accession code E-MTAB-8901 (https://www.ebi.ac.uk/biostudies/arrayexpress/studies/E-MTAB-8901). the terms sex (biological attribute) and gender (shaped by social and cultural circumstances) carefully in order to avoid confusing both terms.Indicate if findings apply to only one sex or gender; describe whether sex and gender were considered in study design; whether sex and/or gender was determined based on self-reporting or assigned and methods used.Provide in the source data disaggregated sex and gender data, where this information has been collected, and if consent has been obtained for sharing of individual-level data; provide overall numbers in this Reporting Summary.Please state if this information has not been collected.Report sex-and gender-based analyses where performed, justify reasons for lack of sex-and gender-based analysis.Please specify the socially constructed or socially relevant categorization variable(s) used in your manuscript and explain why they were used.Please note that such variables should not be used as proxies for other socially constructed/relevant variables (for example, race or ethnicity should not be used as a proxy for socioeconomic status).Provide clear definitions of the relevant terms used, how they were provided (by the participants/respondents, the researchers, or third parties), and the method(s) used to classify people into the different categories (e.g.self-report, census or administrative data, social media data, etc.) Please provide details about how you controlled for confounding variables in your analyses.The PDO model used in most of the in vitro experiments has been previously described and referred to as PDO7 inCortina et  al. 2017 and Lombardo et al. 2011.PDO-p18 is described in van de Wetering et al. 2015.The two models were obtained from from CRC patients undergoing CR resection, in accordance with the ethical standards of the institutional committee.